The Impact of Cytochrome P450 Abnormalities in Patients With Delirium. A Pilot Study.

Status: Completed
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Objectives: 1. To examine whether patients with delirium have higher prevalence of cytochrome-P450 abnormalities compared to patients without delirium. 2. To examine whether the severity of delirium is related to a specific cytochrome P450 genotype. 3. To examine the persistence of delirium at 6-8 weeks stratified by presence of cytochrome p450 abnormalities 4. To examine whether delirium persistence is impacted by types of medications administered during their hospital stay.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Patients age 18 and older admitted to the ALGH (Advocate Lutheran General Hospital) rehabilitation unit

• One or more of the Following Principle Diagnosis:

• Principle stroke diagnosis Principle Cardiac-Post cardiac surgery Principle Spinal surgery

• Non-English speakers are not anticipated. However, there is an available interpreter services already on the unit and this interpreter's services will be utilized. https://www.languageline.com/ However, we will utilize that AHC IRB approved short forms if a potential subject presents itself.

Locations
United States
Illinois
Advocate Health Care
Park Ridge
Time Frame
Start Date: 2019-01-31
Completion Date: 2020-06-24
Participants
Target number of participants: 13
Treatments
Delirium Group
1. UBACC: University of California, San Diego Brief Assessment of Capacity to Consent.~2. The participant may decline participation after this UBACC (University of California, San Diego Brief Assessment of Capacity to Consent) assessment and will be removed from the study.~3. The Short IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly) is administered to the legally authorized representative or caregiver by Dr. Schmidt. If the potential participant scores 3.3 or lower, the participant will continue in the delirium group. If higher, patient likely with pre-existing dementia. These patients are not eligible for study participation.~4. Delirium Rating Scale 98 will be performed on the ALGH (Advocate Lutheran General Hospital) rehabilitation unit~5. Cytochrome P450 testing~6. Delirium Status: Admission, Hospital Discharge, Outpatient Visit~7. FIM (The Functional Independence Measure) scores on admission and discharge. FIM efficiency score.
Patients without delirium
1. Cytochrome P450 testing~2. Delirium Status: Admission, Hospital Discharge, Outpatient Visit~3. FIM (The Functional Independence Measure) scores on admission and discharge. FIM efficiency score.
Authors
Mary Schmidt, David I Ronin
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences

This content was sourced from clinicaltrials.gov